Delivery Order SPE2DR25D2104-SPE2DR26F3PFU
- Not listed
- The Defense Logistics Agency awarded a $7,471 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for supply of Nemluvio 30 mg pens. The contract is a firm fixed-price, competitive award with no set-aside designation and is scheduled for completion by November 28, 2025. AmerisourceBergen will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by October 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,735.44 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on November 14, 2025, with completion expected by December 8, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,787.60 delivery order on July 14, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $5,787.60 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of October 21, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Nemluvio 30 mg pens, with a ceiling value of $1,867.72. This firm fixed-price delivery order is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $1,867.72 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $1,929.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Nemluvio 30 mg pens. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 9, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $3,735.44 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with performance in Conshohocken, Pennsylvania and an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PFUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,603.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded contract, with no set-aside designation, was issued on November 17, 2025, and carries an ultimate completion date of December 9, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, under firm fixed pricing terms. This delivery order is issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for federal medical procurement, particularly within the military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/17/25 |